CP-169 Influence of concomitant treatment with statins on survival outcomes of patients with metastatic castration resistant prostate cancer receiving abiraterone as firstline therapy

BackgroundPrevious studies have analysed the effect of statins on the response duration to androgen deprivation therapy in metastatic prostate cancer (mCRPC)1 but without using abiraterone.PurposeThe aim of this study was to explore whether statins affect survival outcomes in our population of mCRPC...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2017-03, Vol.24 (Suppl 1), p.A76-A76
Hauptverfasser:	Lores, M Tourís, Paisán, E Espino, Montero, E López, López, C González-Anleo, Ferrán, B Bernárdez, Lamas, MJ
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgens Cancer therapies Metastasis Prostate cancer Statins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!